Cargando…
P1187: SAFETY AND EFFICACY OF ANTICD20-CD3 BISPECIFIC T-CELL ENGAGING ANTIBODIES IN THE MANAGEMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430938/ http://dx.doi.org/10.1097/01.HS9.0000971644.99947.f4 |
| _version_ | 1785091079747403776 |
|---|---|
| author | Rahman, Mansoor Khan, Babar Mukhopadhyay, Debduti Wahab, Qazi Muhammad Farooq Khan, Saifullah Khalil, Mazhar Ali Shaukat, Muqsit Khan, Rafiullah |
| author_facet | Rahman, Mansoor Khan, Babar Mukhopadhyay, Debduti Wahab, Qazi Muhammad Farooq Khan, Saifullah Khalil, Mazhar Ali Shaukat, Muqsit Khan, Rafiullah |
| author_sort | Rahman, Mansoor |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430938 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309382023-08-17 P1187: SAFETY AND EFFICACY OF ANTICD20-CD3 BISPECIFIC T-CELL ENGAGING ANTIBODIES IN THE MANAGEMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS Rahman, Mansoor Khan, Babar Mukhopadhyay, Debduti Wahab, Qazi Muhammad Farooq Khan, Saifullah Khalil, Mazhar Ali Shaukat, Muqsit Khan, Rafiullah Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430938/ http://dx.doi.org/10.1097/01.HS9.0000971644.99947.f4 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Rahman, Mansoor Khan, Babar Mukhopadhyay, Debduti Wahab, Qazi Muhammad Farooq Khan, Saifullah Khalil, Mazhar Ali Shaukat, Muqsit Khan, Rafiullah P1187: SAFETY AND EFFICACY OF ANTICD20-CD3 BISPECIFIC T-CELL ENGAGING ANTIBODIES IN THE MANAGEMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS |
| title | P1187: SAFETY AND EFFICACY OF ANTICD20-CD3 BISPECIFIC T-CELL ENGAGING ANTIBODIES IN THE MANAGEMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS |
| title_full | P1187: SAFETY AND EFFICACY OF ANTICD20-CD3 BISPECIFIC T-CELL ENGAGING ANTIBODIES IN THE MANAGEMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS |
| title_fullStr | P1187: SAFETY AND EFFICACY OF ANTICD20-CD3 BISPECIFIC T-CELL ENGAGING ANTIBODIES IN THE MANAGEMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS |
| title_full_unstemmed | P1187: SAFETY AND EFFICACY OF ANTICD20-CD3 BISPECIFIC T-CELL ENGAGING ANTIBODIES IN THE MANAGEMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS |
| title_short | P1187: SAFETY AND EFFICACY OF ANTICD20-CD3 BISPECIFIC T-CELL ENGAGING ANTIBODIES IN THE MANAGEMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS |
| title_sort | p1187: safety and efficacy of anticd20-cd3 bispecific t-cell engaging antibodies in the management of relapsed/refractory diffuse large b-cell lymphoma: a systematic review of clinical trials |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430938/ http://dx.doi.org/10.1097/01.HS9.0000971644.99947.f4 |
| work_keys_str_mv | AT rahmanmansoor p1187safetyandefficacyofanticd20cd3bispecifictcellengagingantibodiesinthemanagementofrelapsedrefractorydiffuselargebcelllymphomaasystematicreviewofclinicaltrials AT khanbabar p1187safetyandefficacyofanticd20cd3bispecifictcellengagingantibodiesinthemanagementofrelapsedrefractorydiffuselargebcelllymphomaasystematicreviewofclinicaltrials AT mukhopadhyaydebduti p1187safetyandefficacyofanticd20cd3bispecifictcellengagingantibodiesinthemanagementofrelapsedrefractorydiffuselargebcelllymphomaasystematicreviewofclinicaltrials AT wahabqazimuhammadfarooq p1187safetyandefficacyofanticd20cd3bispecifictcellengagingantibodiesinthemanagementofrelapsedrefractorydiffuselargebcelllymphomaasystematicreviewofclinicaltrials AT khansaifullah p1187safetyandefficacyofanticd20cd3bispecifictcellengagingantibodiesinthemanagementofrelapsedrefractorydiffuselargebcelllymphomaasystematicreviewofclinicaltrials AT khalilmazhar p1187safetyandefficacyofanticd20cd3bispecifictcellengagingantibodiesinthemanagementofrelapsedrefractorydiffuselargebcelllymphomaasystematicreviewofclinicaltrials AT alishaukatmuqsit p1187safetyandefficacyofanticd20cd3bispecifictcellengagingantibodiesinthemanagementofrelapsedrefractorydiffuselargebcelllymphomaasystematicreviewofclinicaltrials AT khanrafiullah p1187safetyandefficacyofanticd20cd3bispecifictcellengagingantibodiesinthemanagementofrelapsedrefractorydiffuselargebcelllymphomaasystematicreviewofclinicaltrials |